康希诺2024年净亏损收窄74.45% 宣布与沙特SPIMACO签署疫苗合作协议

每日经济新闻
25 Mar

每经记者 林姿辰 每经编辑 董兴生3月25日晚间,康希诺(688185.SH,股价58.2元,市值144.02亿元)发布2024年年报,公司去年全年实现营业收入8.46亿元,同比增加137.01%;归属于母公司所有者的净亏损3.79亿元,亏损同比收窄74.45%。公司表示,上年同期(2023年)受到新冠疫苗预估退货影响,当期冲减营业收入2.53亿元,剔除该影响,上年同期集团(康希诺及合并...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10